The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

New York Governor Kathy Hochul has announced inflation refund checks of up to $500 will be paid to eligible New Yorkers.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

As Australia’s obsession with tanning rages on, people are turning to nasal sprays as a ‘safer’ way to tan. Experts say there ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... plans and options to determine the best way to incorporate Spravato into their care ...